NCT02904954 2023-10-11
Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer
Weill Medical College of Cornell University
Phase 2 Completed
Weill Medical College of Cornell University
H. Lee Moffitt Cancer Center and Research Institute
University Hospital, Rouen
Federico II University